Comune di Gorizia: Go! 2025 honors Ungaretti and the Carso he lived through

Share

The great success of the exhibition on Warhol

Transalpina Square
Transalpina Square

Go!2025, approaching its official inauguration on February 8 with the Heads of State of Italy and Slovenia, honors Giuseppe Ungaretti in his dual "role" as soldier and poet on the Carso during World War I.

  The exhibition, open until May 4, spans the Museo di Santa Chiara in Gorizia and the Galleria Comunale d'Arte Contemporanea in Monfalcone. The Gorizia section offers a complete narrative of Ungaretti's experiences on the Carso, detailing his battles, moments of rest behind the lines, leaves, and stories of the places on the Carso, highlighting their unique morphological features.

  In contrast to Ungaretti's poetry, the material and iconographic works displayed at the scenographic and elegant Palazzo Attems Petzenstein showcase the iconic Andy Warhol Factory, which relocates from New York for the exhibition Andy Warhol Beyond Borders. This exhibit has seen an impressive number of visitors in its first week and visiting hours have been extended to accommodate the demand.

  Overlooking both cities, designated European Capitals of Culture, is the castle, built in the 11th century and reconstructed in the 1930s in a circular shape. Protected by its ramparts, it is the most faithful architectural witness since the Middle Ages. It offers a vantage point to enjoy the panoramic view of the entire city and the Church of Sant'Ignazio overlooking the central and key Piazza della Vittoria.

  From there, one can walk to Piazza della Transalpina, another place of great historical significance. In 1947, the border was drawn, splitting the square in half and constructing the Iron Curtain wall right in the middle, the only barrier in Italy. It was like Berlin, but in this case, it lasted longer—until 2004! Until 1954, barbed wire ran through, and the entrance to the train station was blocked.

  The ceremony to open the first borderless European Capital of culture will occur there in two weeks.

Press contact: Francesco De Filippo (+39 040 415181; francesco.defilippo@ansa.it)

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Prof Dr Klemens Joos back as CEO of the EUTOP Group14.5.2025 13:27:53 CEST | Press release

Brussels - Prof Dr Klemens Joos (56) has been back at the helm of the EUTOP Group as CEO since 13 May 2025. The background to this is an ambitious growth strategy up to 2035 for the EUTOP Group, which he founded in 1990 while studying business administration at the Ludwig Maximilian University (LMU) in Munich. Just one year after its foundation, the company had a representative office in Brussels. Today, the EUTOP Group has subsidiaries or representative offices in the capitals of all major European Union member states in addition to Brussels. Prof Dr Klemens Joos is also an honorary professor of ‘Business Administration - Political Stakeholder Management’ at the Technical University of Munich (TUM). Enquiries & Contact: Press department EUTOP Group +49 89 323700-0 eutop@eutop.eu

Biomay Launches FDA-Grade CRISPR/Cas9 Nuclease for Off-the-Shelf Purchase9.5.2025 12:00:00 CEST | Press release

(Vienna, Austria) Biomay, a leading manufacturer of recombinant proteins, today announced the commercial availability of its CRISPR/Cas9 nuclease, marking a significant addition to its off-the-shelf product portfolio for genome-editing applications. Clients purchasing Biomay´s Cas9 will benefit from the company´s unparalleled track record and expertise as a market-registered GMP-manufacturer of the nuclease. Biomay is the FDA-approved manufacturer of recombinant Cas9 as the essential component of CASGEVY®, the very first CRISPR genome editing product on the market. Biomay’s Cas9 (internal code “BMC9”) is based on the classical wild-type Cas9 nuclease from Streptococcus pyogenes. The Cas9 manufacturing process has been de novo developed, GMP-implemented and PPQ-validated by Biomay. GMP and RUO manufacturing is performed by fermentation with E. coli and by purification with chromatographic methods. By quality control with a comprehensive set of validated analytical assays, the consistent

mAInthink GmbH: Technological Breakthrough: Hallucination-Free Superintelligence Achieves 99.99% Strategic Accuracy – Germany Gains Permanent Strategic Superiority9.5.2025 10:57:00 CEST | Press release

Worms, May 9, 2025 – The mAInthink GmbH has achieved a technological breakthrough that redefines the future of strategic decision-making: With the development of StratePlan, a hallucination-free superintelligence delivering verified 99.99% strategic accuracy, Germany secures permanent technological, economic, and geopolitical superiority – operationally deployable and scientifically validated.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye